Literature DB >> 20036906

Nitroxyl enhances myocyte Ca2+ transients by exclusively targeting SR Ca2+-cycling.

Mark J Kohr1, Nina Kaludercic, Carlo G Tocchetti, Wei Dong Gao, David A Kass, Paul M L Janssen, Nazareno Paolocci, Mark T Ziolo.   

Abstract

Nitroxyl (HNO), the 1-electron reduction product of nitric oxide, improves myocardial contraction in normal and failing hearts. Here we test whether the HNO donor Angeli's salt (AS) will change myocyte action potential (AP) waveform by altering the L-type Ca2+ current (ICa) and contrast the contractile effects of HNO with that of the hydroxyl radical (.OH) and nitrite (NO2-), two potential breakdown products of AS. We confirmed the positive effect of AS/HNO on basal cardiomyocyte function, as opposed to the detrimental effect of .OH and the negligible effect of NO2-. Upon examination of the myocyte AP, we observed no change in resting membrane potential or AP duration to 20 per cent repolarization with AS/HNO, whereas AP duration to 90 per cent repolarization was slightly prolonged. However, perfusion with AS/HNO did not elicit a change in basal ICa, but did hasten ICa inactivation. Upon further examination of the SR, the AS/HNO-induced increase in cardiomyocyte Ca2+ transients was abolished with inhibition of SR Ca2+-cycling. Therefore, the HNO-induced increase in Ca2+ transients results exclusively from changes in SR Ca2+-cycling, and not from ICa.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20036906      PMCID: PMC3057191          DOI: 10.2741/e118

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  41 in total

1.  A model for early afterdepolarizations: induction with the Ca2+ channel agonist Bay K 8644.

Authors:  C T January; J M Riddle; J J Salata
Journal:  Circ Res       Date:  1988-03       Impact factor: 17.367

2.  Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current.

Authors:  C T January; J M Riddle
Journal:  Circ Res       Date:  1989-05       Impact factor: 17.367

3.  Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy.

Authors:  A J Burger; U Elkayam; M T Neibaur; H Haught; J Ghali; D P Horton; D Aronson
Journal:  Am J Cardiol       Date:  2001-07-01       Impact factor: 2.778

4.  Nitroxyl increases force development in rat cardiac muscle.

Authors:  Tieying Dai; Ye Tian; Carlo Gabriele Tocchetti; Tatsuo Katori; Anne M Murphy; David A Kass; Nazareno Paolocci; Wei Dong Gao
Journal:  J Physiol       Date:  2007-03-01       Impact factor: 5.182

5.  Endothelial nitric oxide synthase decreases beta-adrenergic responsiveness via inhibition of the L-type Ca2+ current.

Authors:  Honglan Wang; Mark J Kohr; Debra G Wheeler; Mark T Ziolo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-01-18       Impact factor: 4.733

6.  Targeting of phospholamban by peroxynitrite decreases beta-adrenergic stimulation in cardiomyocytes.

Authors:  Mark J Kohr; Honglan Wang; Debra G Wheeler; Murugesan Velayutham; Jay L Zweier; Mark T Ziolo
Journal:  Cardiovasc Res       Date:  2007-09-19       Impact factor: 10.787

Review 7.  Examining nitroxyl in biological systems.

Authors:  Jon M Fukuto; Matthew I Jackson; Nina Kaludercic; Nazareno Paolocci
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

8.  Formation of nitroxyl and hydroxyl radical in solutions of sodium trioxodinitrate: effects of pH and cytotoxicity.

Authors:  Juliana Ivanova; Guy Salama; Robert M Clancy; Nina F Schor; Karen D Nylander; Detcho A Stoyanovsky
Journal:  J Biol Chem       Date:  2003-08-14       Impact factor: 5.157

9.  Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase.

Authors:  G M Wahler; S J Dollinger
Journal:  Am J Physiol       Date:  1995-01

10.  Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling.

Authors:  Carlo G Tocchetti; Wang Wang; Jeffrey P Froehlich; Sabine Huke; Miguel A Aon; Gerald M Wilson; Giulietta Di Benedetto; Brian O'Rourke; Wei Dong Gao; David A Wink; John P Toscano; Manuela Zaccolo; Donald M Bers; Hector H Valdivia; Heping Cheng; David A Kass; Nazareno Paolocci
Journal:  Circ Res       Date:  2006-11-30       Impact factor: 17.367

View more
  19 in total

Review 1.  A recent history of nitroxyl chemistry, pharmacology and therapeutic potential.

Authors:  Jon M Fukuto
Journal:  Br J Pharmacol       Date:  2018-07-01       Impact factor: 8.739

Review 2.  Abnormal Ca(2+) cycling in failing ventricular myocytes: role of NOS1-mediated nitroso-redox balance.

Authors:  Mark T Ziolo; Steven R Houser
Journal:  Antioxid Redox Signal       Date:  2014-08-07       Impact factor: 8.401

Review 3.  Playing with cardiac "redox switches": the "HNO way" to modulate cardiac function.

Authors:  Carlo G Tocchetti; Brian A Stanley; Christopher I Murray; Vidhya Sivakumaran; Sonia Donzelli; Daniele Mancardi; Pasquale Pagliaro; Wei Dong Gao; Jennifer van Eyk; David A Kass; David A Wink; Nazareno Paolocci
Journal:  Antioxid Redox Signal       Date:  2011-03-03       Impact factor: 8.401

Review 4.  Nitroxyl (HNO) for treatment of acute heart failure.

Authors:  Alessia Arcaro; Giuseppe Lembo; Carlo G Tocchetti
Journal:  Curr Heart Fail Rep       Date:  2014-09

5.  Obligatory role of neuronal nitric oxide synthase in the heart's antioxidant adaptation with exercise.

Authors:  Steve R Roof; Hsiang-Ting Ho; Sean C Little; Joseph E Ostler; Elizabeth A Brundage; Muthu Periasamy; Frederick A Villamena; Sandor Györke; Brandon J Biesiadecki; Christophe Heymes; Steven R Houser; Jonathan P Davis; Mark T Ziolo
Journal:  J Mol Cell Cardiol       Date:  2015-01-14       Impact factor: 5.000

Review 6.  Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure.

Authors:  Barbara K Kemp-Harper; John D Horowitz; Rebecca H Ritchie
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

7.  Nitroxyl (HNO): A novel approach for the acute treatment of heart failure.

Authors:  Hani N Sabbah; Carlo Gabriele Tocchetti; Mengjun Wang; Samantapudi Daya; Ramesh C Gupta; Richard S Tunin; Reza Mazhari; Eiki Takimoto; Nazareno Paolocci; Douglas Cowart; Wilson S Colucci; David A Kass
Journal:  Circ Heart Fail       Date:  2013-10-09       Impact factor: 8.790

8.  Synthesis and chemical and biological comparison of nitroxyl- and nitric oxide-releasing diazeniumdiolate-based aspirin derivatives.

Authors:  Debashree Basudhar; Gaurav Bharadwaj; Robert Y Cheng; Sarthak Jain; Sa Shi; Julie L Heinecke; Ryan J Holland; Lisa A Ridnour; Viviane M Caceres; Regina C Spadari-Bratfisch; Nazareno Paolocci; Carlos A Velázquez-Martínez; David A Wink; Katrina M Miranda
Journal:  J Med Chem       Date:  2013-10-08       Impact factor: 7.446

9.  HNO enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerization.

Authors:  Vidhya Sivakumaran; Brian A Stanley; Carlo G Tocchetti; Jeff D Ballin; Viviane Caceres; Lufang Zhou; Gizem Keceli; Peter P Rainer; Dong I Lee; Sabine Huke; Mark T Ziolo; Evangelia G Kranias; John P Toscano; Gerald M Wilson; Brian O'Rourke; David A Kass; James E Mahaney; Nazareno Paolocci
Journal:  Antioxid Redox Signal       Date:  2013-10-10       Impact factor: 8.401

10.  Nitroxyl-mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function.

Authors:  Wei Dong Gao; Christopher I Murray; Ye Tian; Xin Zhong; Jenna F DuMond; Xiaoxu Shen; Brian A Stanley; D Brian Foster; David A Wink; S Bruce King; Jennifer E Van Eyk; Nazareno Paolocci
Journal:  Circ Res       Date:  2012-07-31       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.